KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Labcorp Holdings (LH) over the last 8 years, with Q3 2025 value amounting to $700000.0.

  • Labcorp Holdings' Asset Writedowns and Impairment changed N/A to $700000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 million, marking a year-over-year decrease of 9895.93%. This contributed to the annual value of $5.3 million for FY2024, which is 9848.14% down from last year.
  • As of Q3 2025, Labcorp Holdings' Asset Writedowns and Impairment stood at $700000.0.
  • Labcorp Holdings' Asset Writedowns and Impairment's 5-year high stood at $333.8 million during Q4 2023, with a 5-year trough of $700000.0 in Q3 2025.
  • In the last 4 years, Labcorp Holdings' Asset Writedowns and Impairment had a median value of $2.8 million in 2023 and averaged $68.5 million.
  • Its Asset Writedowns and Impairment has fluctuated over the past 5 years, first surged by 8333.33% in 2023, then tumbled by 9916.12% in 2024.
  • Quarter analysis of 4 years shows Labcorp Holdings' Asset Writedowns and Impairment stood at $260.5 million in 2022, then increased by 28.14% to $333.8 million in 2023, then plummeted by 99.16% to $2.8 million in 2024, then plummeted by 75.0% to $700000.0 in 2025.
  • Its last three reported values are $700000.0 in Q3 2025, $2.8 million for Q4 2024, and $2.5 million during Q1 2024.